Paper8922256
Blockade of the KATP-channel by glibenclamide aggravates ischemic injury, and counteracts ischemic preconditioning.
Munch-Ellingsen J and 2 others. Basic Res Cardiol, 1996. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. Blockade of the KATP-channel by glibenclamide aggravates ischemic injury, and counteracts ischemic preconditioning. Papers, record 8922256. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8922256
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Blockade of the KATP-channel by glibenclamide aggravates ischemic injury, and counteracts ischemic preconditioning.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glyburide | Major topic |
| Hypoglycemic Agents | Major topic |
| Ischemic Preconditioning, Myocardial | Major topic |
| Myocardial Infarction | Major topic |
| Potassium Channel Blockers | Major topic |
| Animals | |
| Female | |
| Hemodynamics | |
| Male | |
| Rabbits |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1415759 | Ischemic preconditioning protects against infarction in rat heart. | Am J Physiol | 1992 | https://conductscience.org/library/papers/1415759 | PubMed |
| 2 | 1310443 | Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. | Circ Res | 1992 | https://conductscience.org/library/papers/1310443 | PubMed |
| 3 | 8324795 | Limitation of infarct size in the rabbit by ischaemic preconditioning is reversible with glibenclamide. | Cardiovasc Res | 1993 | https://conductscience.org/library/papers/8324795 | PubMed |
| 4 | 8380263 | Blockade of ATP-sensitive potassium channels increases infarct size but does not prevent preconditioning in rabbit hearts. | Circ Res | 1993 | https://conductscience.org/library/papers/8380263 | PubMed |
| 5 | 8124811 | A comparison of adenosine-induced cardioprotection and ischemic preconditioning in dogs. Efficacy, time course, and role of KATP channels. | Circulation | 1994 | https://conductscience.org/library/papers/8124811 | PubMed |
| 6 | 8072020 | Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. | J Mol Cell Cardiol | 1994 | https://conductscience.org/library/papers/8072020 | PubMed |
| 7 | 1750525 | Adenosine triphosphate-sensitive potassium channels in the cardiovascular system. | Am J Physiol | 1991 | https://conductscience.org/library/papers/1750525 | PubMed |
| 8 | 1836311 | Effects of glibenclamide and nicorandil on cardiac function during ischemia and reperfusion in isolated perfused rat hearts. | Am J Physiol | 1991 | https://conductscience.org/library/papers/1836311 | PubMed |
| 9 | 1908355 | Sulfonylureas, ATP-sensitive K+ channels, and cellular K+ loss during hypoxia, ischemia, and metabolic inhibition in mammalian ventricle. | Circ Res | 1991 | https://conductscience.org/library/papers/1908355 | PubMed |
| 10 | 8044938 | Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker. | Circulation | 1994 | https://conductscience.org/library/papers/8044938 | PubMed |
| 11 | 8160817 | Preconditioning protects ischemic rabbit heart by protein kinase C activation. | Am J Physiol | 1994 | https://conductscience.org/library/papers/8160817 | PubMed |
| 12 | 1593462 | ATP-sensitive K+ channels and cellular K+ loss in hypoxic and ischaemic mammalian ventricle. | J Physiol | 1992 | https://conductscience.org/library/papers/1593462 | PubMed |
| 13 | 2122259 | Modification by glibenclamide of the electrophysiological consequences of myocardial ischaemia in dogs and rabbits. | Naunyn Schmiedebergs Arch Pharmacol | 1990 | https://conductscience.org/library/papers/2122259 | PubMed |
| 14 | 8585864 | Perfusion delay causes unintentional ischemic preconditioning in isolated heart preparation. | Basic Res Cardiol | 1995 | https://conductscience.org/library/papers/8585864 | PubMed |
| 15 | 2102815 | Regulation of the ATP-sensitive potassium channel. | Ion Channels | 1990 | https://conductscience.org/library/papers/2102815 | PubMed |
| 16 | 8324799 | Ischaemic preconditioning delays ischaemia induced cellular electrical uncoupling in rabbit myocardium by activation of ATP sensitive potassium channels. | Cardiovasc Res | 1993 | https://conductscience.org/library/papers/8324799 | PubMed |
| 17 | 2440431 | The antidiabetic sulfonylurea glibenclamide is a potent blocker of the ATP-modulated K+ channel in insulin secreting cells. | Biochem Biophys Res Commun | 1987 | https://conductscience.org/library/papers/2440431 | PubMed |
| 18 | 7943380 | Involvement of activation of ATP-dependent potassium channels in ischemic preconditioning in swine. | Am J Physiol | 1994 | https://conductscience.org/library/papers/7943380 | PubMed |
| 19 | 1762089 | The new K+ channel opener Aprikalim (RP 52891) reduces experimental infarct size in dogs in the absence of hemodynamic changes. | J Pharmacol Exp Ther | 1991 | https://conductscience.org/library/papers/1762089 | PubMed |
| 20 | 2456760 | The potassium channel opener cromakalim (BRL 34915) activates ATP-dependent K+ channels in isolated cardiac myocytes. | Biochem Biophys Res Commun | 1988 | https://conductscience.org/library/papers/2456760 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 28545784 | Pro- and Antiarrhythmic Actions of Sulfonylureas: Mechanistic and Clinical Evidence. | Trends Endocrinol Metab | 2017 | https://conductscience.org/library/papers/28545784 | PubMed |
| 18055876 | Inhibiting protease-activated receptor 4 limits myocardial ischemia/reperfusion injury in rat hearts by unmasking adenosine signaling. | J Pharmacol Exp Ther | 2008 | https://conductscience.org/library/papers/18055876 | PubMed |
| 17468933 | SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts. | Basic Res Cardiol | 2007 | https://conductscience.org/library/papers/17468933 | PubMed |
| 12746224 | Activation of ATP-dependent potassium channels is a trigger but not a mediator of ischaemic preconditioning in pigs. | Br J Pharmacol | 2003 | https://conductscience.org/library/papers/12746224 | PubMed |
| 9774180 | Equal reduction in infarct size by ethylisopropyl-amiloride pretreatment and ischemic preconditioning in the in situ rabbit heart. | Mol Cell Biochem | 1998 | https://conductscience.org/library/papers/9774180 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8922256
GET https://conductscience.org/api/papers/v1/8922256/references?page=2